(Phnom Penh): Mane Group of the Kingdom of Cambodia and Lao Alliance Pharmaceutical Group (LAPG) of the Lao People’s Democratic Republic officially signed a Memorandum of Understanding (MoU) on 30 November 2025 in Phnom Penh, marking the beginning of a strategic partnership aimed at expanding the pharmaceutical, healthcare, and cosmetics industries in Cambodia.
Under this cooperation, the Parties will establish Phannthamit Pharmaceutical (Cambodia) Import & Export Co., Ltd., a joint venture that will focus on the importation, registration, distribution, and future manufacturing of high-quality medical and health-related products in the Kingdom of Cambodia. This partnership aligns with regional development priorities and seeks to strengthen supply chain resilience and healthcare access across ASEAN.
Lao Alliance Pharmaceutical Group is currently one of the most advanced pharmaceutical manufacturers in the region, operating four modern production facilities in Laos with a combined investment exceeding USD 150 million. These factories produce pharmaceutical, nutraceutical, and cosmetic products for regional and international markets. Through this MoU, LAPG intends not only to supply the Cambodian market, but also to expand its industrial footprint by developing a pharmaceutical manufacturing plant in Cambodia in cooperation with Mane Group.
In addition to manufacturing expansion, the Parties have agreed to begin feasibility discussions on establishing a hospital in Cambodia, combining LAPG’s medical and pharmaceutical expertise with Mane Group’s proven leadership in hospitality, investment, and infrastructure development. This vision reflects a shared commitment to improving healthcare access, enhancing medical services, and contributing to the Kingdom’s long-term socio-economic growth.
Speaking at the signing ceremony, Neak Oknha Key Mane, President & Founder of Mane Group, stated: “This cooperation marks an important milestone for Mane Group as we enter the pharmaceutical and healthcare sectors. We are committed to building a strong foundation for medical innovation in Cambodia, and our partnership with Lao Alliance Pharmaceutical Group demonstrates our ambition to move beyond importation into manufacturing and long-term healthcare development.”
Ting Chen, Chief Executive Officer of Lao Alliance Pharmaceutical Group, affirmed the company’s confidence in Cambodia’s market potential: “With its strategic location, growing population, and supportive investment environment, Cambodia represents a key market for our expansion. Through this partnership, we aim to deliver high-quality products and develop production capacity within Cambodia, while exploring key projects such as hospital development that will bring lasting benefits to both our nations.”
This MoU symbolizes not only a commercial cooperation, but a forward-looking regional initiative that strengthens the strategic partnership between Cambodia and Laos and reinforces the broader vision of ASEAN collaboration in the pharmaceutical and healthcare sectors.
=FRESH NEWS
